Apimeds Pharmaceuticals Us is a pharmaceutical company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker APUS on the NYSEMKT exchange.
Apimeds Pharmaceuticals Us stock last closed at $1.93, up 8.18% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by N/A percentage points. Apimeds Pharmaceuticals Us stock is currently +40.88% from its 52-week low of $1.37, and -51.75% from its 52-week high of $4.00.
As of Sep 26, 2025, there are 12.58M shares of APUS outstanding. The market capitalization of APUS is $24.27M. In the past 24 hours, 88,500 APUS shares were traded.
You need a brokerage account to access the NYSEMKT market and buy APUS shares.
In our opinion, eToro is the best online stock brokerage. Here's why:
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, you need to fill out some personal information so you can buy APUS stock today.
Now that you have filled out your info on the best free stock trading app, you need to deposit funds:
Check out this video walkthrough for more details depositing money into your investment account.
Once you have chosen the best place to buy Apimeds Pharmaceuticals Us stock, it's critical to evaluate their stock prior to investing, so you can comprehend the risk and upside.
WallStreetZen was built to help average investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on APUS's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge APUS's fair value.
Using relative valuations ratios:
You can access more valuation research on APUS's stock here.
In the past 12 months, insiders at APUS have bought more shares than they have sold.
Christopher Kim, Chairman and CMO of APUS, was the latest APUS insider to buy. They bought $14,377.80 worth of APUS stock on May 14, 2025.
Dig into more about who owns APUS shares here.
No, Apimeds Pharmaceuticals Us doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two main options:
Click the Open Trade button and eToro will execute the order.
If you need additional assistance investing in stocks on eToro, watch the helpful video below:
Now that you own some APUS stock, you'll want to stay up-to-date on your new company.
Add APUS to a watchlist to track the latest developments regarding your APUS stock.
To summarize, here are the 6 steps to buy Apimeds Pharmaceuticals Us stock:
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to watch your new investment in Apimeds Pharmaceuticals Us, add APUS to your watchlist by clicking the button below.